Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.
Capraz T, Kienzl NF, Laurent E, Perthold JW, Föderl-Höbenreich E, Grünwald-Gruber C, Maresch D, Monteil V, Niederhöfer J, Wirnsberger G, Mirazimi A, Zatloukal K, Mach L, Penninger JM, Oostenbrink C, Stadlmann J.
Capraz T, et al. Among authors: zatloukal k.
Elife. 2021 Dec 20;10:e73641. doi: 10.7554/eLife.73641.
Elife. 2021.
PMID: 34927585
Free PMC article.